Long term outcomes in patients with ovarian or abdominal cancer who underwent chemotherapy either before or after surgery to remove the affected areas

Neoadjuvant chemotherapy for patients with diaphragmatic lesions: A prognostic postoperative analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN81171658

Enrollment

Registered

2019-11-25

Start date

2019-04-01

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian or peritoneal cancer Cancer Ovarian or peritoneal cancer

Interventions

Between January 2010 and December 2013, patients with epithelial ovarian and peritoneal cancers accompanied with diaphragmatic lesions underwent standard surgery combined with diaphragmatic surgery at

additional four courses of PC were administered following IDS. Furthermore, patients in the NAC group were defined as those in whom complete excision was considered difficult due to a tumour in the ri

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Aged 20 years or above 2. Female 3. Attended surgery between January 2010 and December 2013

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
Survival curve measured using up to date medical records	—

Secondary

Measure	Time frame
1. Overall survival measured using up to date medical records 2. Progression-free survival measured using up to date medical records	—

Countries

Japan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026